Myriad Genetics Sells Prenatal Health Testing Business to LabCorp
1 report, 1 independent
Updated Tue 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Myriad Genetics announced it is selling its Prenatal Health testing business to LabCorp. The transaction includes tests such as Prequel®, Foresight®, SneakPeek®, and FirstGene®. LabCorp will acquire the business for $210 million in cash, plus the value of the inventory.
From manilatimes.net
Why it matters
The sale is expected to be accretive to Myriad Genetics’ revenue growth and profitability while strengthening its balance sheet. The transaction is also expected to provide more patients and physicians with expanded access to LabCorp’s services.
From manilatimes.net
Who's involved
- Myriad GeneticsSeller of the Prenatal Health testing business
- LabCorpBuyer of the Prenatal Health testing business
Keep exploring
The entities involved
-
Myriad Genetics
American biotechnology company
-
LabCorp
clinical laboratory company